Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates
Crossref DOI link: https://doi.org/10.1186/s12962-017-0081-8
Published Online: 2017-09-07
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Harvard, Stephanie
Guh, Daphne
Bansback, Nick
Richette, Pascal
Saraux, Alain
Fautrel, Bruno
Anis, Aslam
Funding for this research was provided by:
Spondyloarthritis Research Consortium of Canada